original ) (raw )Imaging Dopamine Receptors in the Human Brain by Positron Tomography
Scott Lukas
Journal of Computer Assisted Tomography, 1984
View PDFchevron_right
Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796
John Krystal
Journal of Nuclear …, 1996
View PDFchevron_right
Models for In Vivo Kinetic Interactions of Dopamine D2-Neuroreceptors and 3-(2'-[18F]Fluoroethyl)spiperone Examined with Positron Emission Tomography
Sung-cheng Huang
Journal of Cerebral Blood Flow & Metabolism, 1989
View PDFchevron_right
Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models
Iwao Kanno
Annals of Nuclear Medicine, 2010
View PDFchevron_right
Receptor binding and selectivity of three 11C-labelled dopamine receptor antagonists in the brain of Rhesus monkeys studied with positron emission tomography
Bengt Långström
Acta Neurologica Scandinavica, 1988
View PDFchevron_right
Analysis of Four Dopaminergic Tracers Kinetics Using Two Different Tissue Input Function Methods
A Jon Stoessl
Journal of Cerebral Blood Flow and Metabolism, 2000
View PDFchevron_right
Quantitative PET Analysis of the Dopamine D2 Receptor Agonist Radioligand 11C-(R)-2-CH3O-N-n-Propylnorapomorphine in the Human Brain
Lars Farde , Tetsuya Suhara
Journal of Nuclear Medicine, 2009
View PDFchevron_right
Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain
Serge Goldman
Synapse, 1991
View PDFchevron_right
Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography
richard torstenson
Journal of Neural Transmission, 1997
View PDFchevron_right
N-(3-[18F]fluoropropyl)-spiperone: The preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor
C. Dence
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
View PDFchevron_right
Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data
Ole Isacson , Anna-liisa Brownell
Magnetic Resonance in Medicine, 1997
View PDFchevron_right
Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET)
Jonathan Brodie
Synapse, 1991
View PDFchevron_right
Positron emission tomography (PET) studies of dopaminergic/cholinergic interaction in the baboon brain
Jonathan Brodie
Synapse, 1990
View PDFchevron_right
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test–retest reproducibility
S. Anjilvel
Journal of Cerebral Blood Flow & Metabolism, 2008
View PDFchevron_right
Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11 C-N-methyl-spiperone
Bengt Långström
Acta Neurologica Scandinavica, 1987
View PDFchevron_right
Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects
Stephen Dewey
Proceedings of the National Academy of Sciences, 1993
View PDFchevron_right
Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans
Nathaniel Alpert , Bradley Christian
Nuclear Medicine and Biology, 2014
View PDFchevron_right
Kinetics of the uptake and distribution of the dopamine D2,3 agonist (R)-N-[1-11C]n-propylnorapomorphine in brain of healthy and MPTP-treated Göttingen miniature pigs
Nic Gillings , Albert Gjedde
Nuclear Medicine and Biology, 2003
View PDFchevron_right
Quantitation of Carbon-11-labeled raclopride in rat striatum using positron emission tomography
Jolanta Opacka-Juffry
Synapse, 1992
View PDFchevron_right
In vivo evaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography
Gunnar Antoni , Bengt Långström
Acta Neurologica Scandinavica, 1987
View PDFchevron_right
PET Measurement of rCBF in the presence of a neurochemical tracer
Alexander Converse , Robert Nickles
Journal of Neuroscience Methods, 2004
View PDFchevron_right
Quantification of dopamine transporter binding using [18F]FP-β-CIT and positron emission tomography
Bart Van Berckel
Journal of Cerebral Blood Flow & Metabolism, 2007
View PDFchevron_right
Modeling considerations for in vivo quantification of the dopamine transporter using [11C]PE2I and positron emission tomography
Francesca Zanderigo
Journal of Cerebral Blood Flow & Metabolism, 2009
View PDFchevron_right